Shots:

• Sanofi and MD Anderson collaborated for 5yrs. to ramp up the development of investigational treatments- including targeted and immune-therapies for oncology patients. The alliance will support investigations into additional indications and combinations for studies already in the clinic
• The collaboration will integrate MD Anderson's clinical trials infrastructure and Sanofi's pipeline of investigational treatments to lead biomarker-driven clinical studies for better understanding of novel cancer drugs mechanism
• New findings- large-scale molecular and phenotype datasets will be applied to the design of new translational studies on selected Sanofi molecules- and guide the selection of indications. The companies are expected to launch their first projects in summer 2020

Click here to­ read full press release/ article | Ref: Sanofi | Image: TechtrendsKE